273 related articles for article (PubMed ID: 17628615)
1. Genes, diet and inflammatory bowel disease.
Ferguson LR; Shelling AN; Browning BL; Huebner C; Petermann I
Mutat Res; 2007 Sep; 622(1-2):70-83. PubMed ID: 17628615
[TBL] [Abstract][Full Text] [Related]
2. Nutrigenomics and gut health.
Ferguson LR; Shelling AN; Lauren D; Heyes JA; McNabb WC;
Mutat Res; 2007 Sep; 622(1-2):1-6. PubMed ID: 17568628
[TBL] [Abstract][Full Text] [Related]
3. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
4. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
[TBL] [Abstract][Full Text] [Related]
5. DNA-driven nutritional therapy of inflammatory bowel disease.
Lee G; Buchman AL
Nutrition; 2009 Sep; 25(9):885-91. PubMed ID: 19647622
[TBL] [Abstract][Full Text] [Related]
6. Dissecting genetic predisposition to inflammatory bowel disease: current progress and prospective application.
Annese V; Latiano A; Palmieri O; Andriulli A
Expert Rev Clin Immunol; 2007 May; 3(3):287-98. PubMed ID: 20477673
[TBL] [Abstract][Full Text] [Related]
7. Extraintestinal considerations in inflammatory bowel disease.
Levine JB; Lukawski-Trubish D
Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240
[TBL] [Abstract][Full Text] [Related]
8. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
9. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD.
Schulze HA; Häsler R; Mah N; Lu T; Nikolaus S; Costello CM; Schreiber S
Genes Immun; 2008 Apr; 9(3):240-8. PubMed ID: 18340362
[TBL] [Abstract][Full Text] [Related]
10. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
[TBL] [Abstract][Full Text] [Related]
11. The genetics of inflammatory bowel disease.
Van Limbergen J; Russell RK; Nimmo ER; Satsangi J
Am J Gastroenterol; 2007 Dec; 102(12):2820-31. PubMed ID: 17894847
[TBL] [Abstract][Full Text] [Related]
12. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
[TBL] [Abstract][Full Text] [Related]
13. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
14. Joint involvement associated with inflammatory bowel disease.
De Vos M
Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
[TBL] [Abstract][Full Text] [Related]
15. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
Vermeire S
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():2-10. PubMed ID: 16961737
[TBL] [Abstract][Full Text] [Related]
16. Cell culture models in developing nutrigenomics foods for inflammatory bowel disease.
Philpott M; Mackay L; Ferguson LR; Forbes D; Skinner M
Mutat Res; 2007 Sep; 622(1-2):94-102. PubMed ID: 17568627
[TBL] [Abstract][Full Text] [Related]
17. [Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases].
Bouma G; Peña AS
Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2414-20. PubMed ID: 10608975
[TBL] [Abstract][Full Text] [Related]
18. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
Fiocchi C
Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
[TBL] [Abstract][Full Text] [Related]
20. Current status of genetics research in inflammatory bowel disease.
Vermeire S; Rutgeerts P
Genes Immun; 2005 Dec; 6(8):637-45. PubMed ID: 16107869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
